Showing results (211-220 of 283) with videos related to
Sort By:
Pageof 29
The American Journal of Psychiatry|June 30, 2000
Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophreniaX M Gao, K Sakai, R C Roberts, et al.Psychiatry Research|April 1, 1982
A comparison of nine systems to diagnose schizophreniaJ H Stephens, C Astrup, W T Carpenter, et al.The American Journal of Psychiatry|March 1, 1997
Attentional impairments in deficit and nondeficit forms of schizophreniaR W Buchanan, M E Strauss, A Breier, et al.Psychiatry Research|June 29, 1995
Tone discrimination performance in schizophrenic patients and normal volunteers: impact of stimulus presentation levels and frequency differencesH H Holcomb, E K Ritzl, D R Medoff, et al.Molecular Psychiatry|May 1, 2013
Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugsM Yanagi, R H Joho, S A Southcott, et al.The American Journal of Psychiatry|July 13, 1999
Relationship of awareness of dyskinesia in schizophrenia to insight into mental illnessC Arango, H Adami, J D Sherr, et al.The Journal of Nervous and Mental Disease|January 1, 1989
Diazepam treatment of early symptoms of schizophrenic relapseB Kirkpatrick, R W Buchanan, R W Waltrip, et al.Biological Psychiatry|January 27, 1998
Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophreniaA C Lahti, M A Weiler, P K Corey, et al.Journal of Neurochemistry|May 2, 2001
Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjectsY Dwivedi, H S Rizavi, R C Roberts, et al.Neuroscience Letters|January 2, 1986
Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's diseaseN L Foster, C A Tamminga, T L O'Donohue, et al.Pageof 29